Feature Channels:

Article ID: 705504

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

Article ID: 705497

The U.S. Department of Energy has approved the technical scope, cost estimate and plan of work for an upgrade of the Advanced Photon Source, a major storage-ring X-ray source at Argonne.

Article ID: 705451

Article ID: 705422

People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according to a new study in the Journal of Infectious Diseases. The findings may help guide efforts to prevent the often painful skin condition in cancer patients through the use of new vaccines. The large prospective study expands on previous research by examining the risk of shingles before and after a new cancer diagnosis and across a range of cancer types among approximately 240,000 adults in Australia from 2006 to 2015.

Article ID: 705392

A team from the GW School of Medicine and Health Sciences found emerging treatments, such as neurokinin-1 receptor antagonists, were the most promising against prurigo nodularis.

Article ID: 705373

Researchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology.

Article ID: 705336

Conventional math cannot adequately model the interaction of multiple genes over multiple time frames – a necessary foundation for any cancer-fighting drugs. The study, published in “Frontiers in Physiology” by Mahboobeh Ghorbani, Edmond Jonckheere and Paul Bogdan of the Ming Hsieh Department of Electrical Engineering, is the first study that accounts for the memory, cross-dependence and fractality of gene expression

Article ID: 705198

While friends or family members may feel helpless if someone they know suffers from addiction, one UAB physician says hope can start at home.

Article ID: 705327

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and easily find the best clinicians or pioneering scientists specializing in a wide range of medical conditions or biomedical topics.

Article ID: 705271

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that the lowest priced generic drugs are at a substantially elevated risk of experiencing a drug shortage, and that periods of drug shortages are associated with only modest increases in drug prices.